Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism.
Escarcega RD, Vijay Kumar MJ, Kyriakopoulos VE, Ortiz GJ, Gusdon AM, Fan H, Peesh P, Conesa MPB, Colpo GD, Ahnstedt HW, Couture L, Kim SH, Hinojosa M, Farrell CM, Marrelli SP, Urayama A, Ganesh BP, Schulz PE, McCullough LD, Tsvetkov AS. Escarcega RD, et al. Among authors: kim sh. bioRxiv [Preprint]. 2024 Nov 13:2024.11.11.623108. doi: 10.1101/2024.11.11.623108. bioRxiv. 2024. Update in: Neurobiol Dis. 2024 Nov 29;204:106747. doi: 10.1016/j.nbd.2024.106747 PMID: 39605322 Free PMC article. Updated. Preprint.
Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism.
Escarcega RD, M J VK, Kyriakopoulos VE, Ortiz GJ, Gusdon AM, Fan H, Peesh P, Blasco Conesa MP, Colpo GD, Ahnstedt HW, Couture L, Kim SH, Hinojosa M, Farrell CM, Marrelli SP, Urayama A, Ganesh BP, Schulz PE, McCullough LD, Tsvetkov AS. Escarcega RD, et al. Among authors: kim sh. Neurobiol Dis. 2024 Nov 29;204:106747. doi: 10.1016/j.nbd.2024.106747. Online ahead of print. Neurobiol Dis. 2024. PMID: 39617329 Free article.
A Prospective, Single-Cohort, Open, Multi-Center, Observational Study of Sublingual Fentanyl for Breakthrough Cancer Pain: Effectiveness, Safety, and Tolerability in Korean Cancer Patients.
Choi YS, Koh SJ, Bae WK, Kim SH, Shin SH, Oh SY, Bae SB, Yang Y, Song EK, Cho YY, Lee PB, Oh HS, Lee M, Ahn JS. Choi YS, et al. Among authors: kim sh. Cancer Res Treat. 2024 Dec 26. doi: 10.4143/crt.2024.557. Online ahead of print. Cancer Res Treat. 2024. PMID: 39727011
25,232 results
You have reached the last available page of results. Please see the User Guide for more information.